You Q - Search Results

1

Current Development of ROS-Modulating Agents as Novel Antitumor Therapy.

Wang N, Wu Y, Bian J, Qian X, Lin H, Sun H, You Q, Zhang X. Wang N, et al. Among authors: you q. Curr Cancer Drug Targets. 2017;17(2):122-136. doi: 10.2174/1568009616666160216125833. Curr Cancer Drug Targets. 2017. PMID: 26881931 Review.

2

Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG(2) cells.

Chen FH, Zhang LB, Qiang L, Yang Z, Wu T, Zou MJ, Tao L, You QD, Li ZY, Yang Y, Guo QL. Chen FH, et al. Cancer Lett. 2010 Oct 1;296(1):96-105. doi: 10.1016/j.canlet.2010.04.004. Epub 2010 May 23. Cancer Lett. 2010. PMID: 20580989

3

Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.

Tan Y, Chen Y, You Q, Sun H, Li M. Tan Y, et al. Among authors: you q. J Mol Model. 2012 Mar;18(3):1023-36. doi: 10.1007/s00894-011-1136-y. Epub 2011 Jun 10. J Mol Model. 2012. PMID: 21660488

4

Combination of pharmacophore model development and binding mode analyses: identification of ligand features essential for IκB kinase-beta (IKKβ) inhibitors and virtual screening based on it.

Sun HP, Zhu J, Chen FH, Zhang SL, Zhang Y, You QD. Sun HP, et al. Eur J Med Chem. 2011 Sep;46(9):3942-52. doi: 10.1016/j.ejmech.2011.05.066. Epub 2011 Jun 25. Eur J Med Chem. 2011. PMID: 21708416

5

Synthesis and evaluation of novel aza-caged Garcinia xanthones.

Zhang X, Li X, Sun H, Jiang Z, Tao L, Gao Y, Guo Q, You Q. Zhang X, et al. Among authors: you q. Org Biomol Chem. 2012 Apr 28;10(16):3288-99. doi: 10.1039/c2ob07088j. Epub 2012 Mar 12. Org Biomol Chem. 2012. PMID: 22407464

6

Studies on gambogic acid (IV): Exploring structure-activity relationship with IκB kinase-beta (IKKβ).

Sun H, Chen F, Wang X, Liu Z, Yang Q, Zhang X, Zhu J, Qiang L, Guo Q, You Q. Sun H, et al. Among authors: you q. Eur J Med Chem. 2012 May;51:110-23. doi: 10.1016/j.ejmech.2012.02.029. Epub 2012 Mar 3. Eur J Med Chem. 2012. PMID: 22472167

7

Synthesis, SAR and biological evaluation of natural and non-natural hydroxylated and prenylated xanthones as antitumor agents.

Zhang X, Li X, Ye S, Zhang Y, Tao L, Gao Y, Gong D, Xi M, Meng H, Zhang M, Gao W, Xu X, Guo Q, You Q. Zhang X, et al. Among authors: you q. Med Chem. 2012 Nov;8(6):1012-25. doi: 10.2174/1573406411208061012. Med Chem. 2012. PMID: 22779801

8

Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39).

Sun HP, Liu ZL, Xue X, Gao Y, Zhang L, Wang JX, Guo QL, You QD. Sun HP, et al. Chem Biodivers. 2012 Aug;9(8):1579-90. doi: 10.1002/cbdv.201100415. Chem Biodivers. 2012. PMID: 22899618

9

LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.

Chen FH, Lu N, Zhang HW, Zhao L, He LC, Sun HP, You QD, Li ZY, Guo QL. Chen FH, et al. Mol Pharmacol. 2012 Nov;82(5):958-71. doi: 10.1124/mol.112.079848. Epub 2012 Aug 21. Mol Pharmacol. 2012. PMID: 22909797

10

Studies on chemical-structure modification and structure-activity relationship of gambogic acid derivatives at carbon(34).

Zhang XJ, Li X, Yang YR, Sun HP, Gao Y, Zhang L, Wang JX, Guo QL, You QD. Zhang XJ, et al. Chem Biodivers. 2012 Oct;9(10):2295-308. doi: 10.1002/cbdv.201200081. Chem Biodivers. 2012. PMID: 23081928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,631 results

Search Page

Filters